Shoichi Kuyama

机构：Iwakuni Medical Center · ORCID：0000-0002-6079-3511

发表论文 205 篇 · 总被引 4529 次 · h-index 21

代表论文

Prognostic impact of actionable driver alterations and efficacy of targeted therapy in lung squamous cell carcinoma: A large-scale nationwide genomic screening (LC-SCRUM-Asia). (2026 · Journal of Clinical Oncology · 被引 1)
Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion) (2026 · Lung Cancer · 被引 1)
Incidence of leptomeningeal metastasis and prognosis after its development in patients with advanced non-small cell lung cancer: a prospective real-world observational study (CS-Lung-003-linked study 37) (2026 · International Journal of Lung Cancer · 被引 1)
Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101) (2026 · The Oncologist)
Data from Patient-Reported Outcomes in FLAURA2: Osimertinib with or without Chemotherapy in Patients with Previously Untreated EGFR-Mutated Advanced Non–Small Cell Lung Cancer (2026)
Supplementary Data from Patient-Reported Outcomes in FLAURA2: Osimertinib with or without Chemotherapy in Patients with Previously Untreated EGFR-Mutated Advanced Non–Small Cell Lung Cancer (2026)